Robotic Surgery & MedTech Adoption

♥ 688 Thanks from members

Robotic surgery and MedTech adoption in 2026 exhibits structural growth, driven by da Vinci 5 expansion, Stryker's Mako, and Medtronic's Hugo FDA clearance, though tempered by valuation resets, capital intensity, and reimbursement hurdles.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Entity & Market Metadata

Sector: Healthcare Industry: Medical Devices & Health Technology Founder: Frederic Moll (Intuitive Surgical) Founder: Yossi Wolf (Mazor Robotics) Leadership: Gary S. Guthart (CEO, Intuitive Surgical) Leadership: Mark J. Augenblick (Key MedTech Leader) Leadership: Geoff Martha (CEO, Medtronic) Holder: The Vanguard Group, Inc. Holder: BlackRock, Inc. Holder: State Street Corporation Holder: Fidelity Management & Research Da Vinci Surgical System Mako SmartRobotics Hugo RAS System CorPath GRX Vascular Robot #Robotic Surgery #MedTech Adoption #Digital Surgery #Minimally Invasive Procedures #Healthcare Technology Trends